AXSM

Axsome Therapeutics, Inc.

Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$168.50

Market Cap

$8.62B

Beta

0.47

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+65.55%

EPS Growth (YoY)+38.40%

Revenue CAGR 3Y+133.68%

P/E Ratio0.0

PEG Ratio—

FCF Yield-1.09%

Debt / Equity2.73

Interest Coverage-25.8x

No credit card required

Already have an account? Sign in to view the full analysis for AXSM.